GenomeNext LLC — Form D
GenomeNext LLC of COLUMBUS, OH, a company, filed a Form D exempt-offering notice with the SEC on 2017-02-21. The offering totals $500K, of which $500K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-02-21
- Form: D
- Accession: 0001667959-17-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $500K
- Amount sold: $500K
- Investors: 5
- Date of first sale: 2017-02-03
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-280985
Issuer
- Name: GenomeNext LLC
- CIK: 0001667959
- Entity type: Limited Liability Company
- Jurisdiction: OHIO
- Incorporated: 2014
- Address: 175 SOUTH 3RD STREET, SUITE 200, COLUMBUS, OH, 43215
- Phone: 301-275-8080
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Craig Atkinson | Director | Columbus, OH |
| Drew Conway | Director | Columbus, OH |
| Hemant Datta | Director | Columbus, OH |
| James Hirmas | Director | Columbus, OH |
| James Hirmas | Executive Officer | Columbus, OH |
Other filings by this issuer (1)
More